AMWL Fundamental Analysis - AMERICAN WELL CORP-CLASS A

Name: AMERICAN WELL CORP-CLASS A (AMWL) Stock
Brand: AMERICAN WELL CORP-CLASS A
Rating: 3.5 (3 reviews)

Fundamental Rating

AMWL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. No worries on liquidiy or solvency for AMWL as it has an excellent financial health rating, but there are worries on the profitability. AMWL is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

AMWL had negative earnings in the past year.

AMWL had a negative operating cash flow in the past year.

In the past 5 years AMWL always reported negative net income.

In the past 5 years AMWL always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -31.56%, AMWL is not doing good in the industry: 62.86% of the companies in the same industry are doing better.

The Return On Equity of AMWL (-44.50%) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-31.56%
ROE	-44.5%
ROIC	N/A

ROA(3y)-61.48%

ROA(5y)-42.59%

ROE(3y)-79.72%

ROE(5y)-54.34%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 52.93%, AMWL is not doing good in the industry: 62.86% of the companies in the same industry are doing better.

AMWL's Gross Margin has declined in the last couple of years.

AMWL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	52.93%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.79%

GM growth 5Y-3.32%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AMWL does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for AMWL has been reduced compared to 1 year ago.

AMWL has less shares outstanding than it did 5 years ago.

There is no outstanding debt for AMWL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -7.23, we must say that AMWL is in the distress zone and has some risk of bankruptcy.

AMWL's Altman-Z score of -7.23 is on the low side compared to the rest of the industry. AMWL is outperformed by 82.86% of its industry peers.

AMWL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-7.23

ROIC/WACCN/A

WACC10.19%

2.3 Liquidity

AMWL has a Current Ratio of 3.14. This indicates that AMWL is financially healthy and has no problem in meeting its short term obligations.

AMWL has a better Current ratio (3.14) than 71.43% of its industry peers.

AMWL has a Quick Ratio of 3.11. This indicates that AMWL is financially healthy and has no problem in meeting its short term obligations.

AMWL has a better Quick ratio (3.11) than 74.29% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.14
Quick Ratio	3.11

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

AMWL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 46.07%, which is quite impressive.

Looking at the last year, AMWL shows a small growth in Revenue. The Revenue has grown by 4.33% in the last year.

The Revenue has been growing by 11.30% on average over the past years. This is quite good.

EPS 1Y (TTM)46.07%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%30.31%

Revenue 1Y (TTM)4.33%

Revenue growth 3Y0.21%

Revenue growth 5Y11.3%

Sales Q2Q%-7.8%

3.2 Future

AMWL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.97% yearly.

AMWL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.64% yearly.

EPS Next Y55.23%

EPS Next 2Y27.23%

EPS Next 3Y20.19%

EPS Next 5Y12.97%

Revenue Next Year-0.84%

Revenue Next 2Y1.11%

Revenue Next 3Y2.87%

Revenue Next 5Y2.64%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMWL. In the last year negative earnings were reported.

Also next year AMWL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as AMWL's earnings are expected to grow with 20.19% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y27.23%

EPS Next 3Y20.19%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for AMWL!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AMERICAN WELL CORP-CLASS A

NYSE:AMWL (11/24/2025, 3:06:04 PM)

+0.16 (+4.17%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Technology

Earnings (Last)11-04 2025-11-04/amc

Earnings (Next)02-10 2026-02-10/amc

Inst Owners40.45%

Inst Owner Change0%

Ins Owners4.21%

Ins Owner Change1.81%

Market Cap64.60M

Revenue(TTM)265.02M

Net Income(TTM)-113.43M

Analysts70.67

Price Target8.89 (122.25%)

Short Float %1.08%

Short Ratio1.44

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)10.58%

Min EPS beat(2)-9.03%

Max EPS beat(2)30.19%

EPS beat(4)3

Avg EPS beat(4)14.89%

Min EPS beat(4)-9.03%

Max EPS beat(4)31.2%

EPS beat(8)6

Avg EPS beat(8)10.08%

EPS beat(12)7

Avg EPS beat(12)-7.18%

EPS beat(16)10

Avg EPS beat(16)-3.2%

Revenue beat(2)2

Avg Revenue beat(2)4.89%

Min Revenue beat(2)1.14%

Max Revenue beat(2)8.64%

Revenue beat(4)4

Avg Revenue beat(4)5.82%

Min Revenue beat(4)1.14%

Max Revenue beat(4)8.93%

Revenue beat(8)4

Avg Revenue beat(8)1.61%

Revenue beat(12)4

Avg Revenue beat(12)-0.13%

Revenue beat(16)5

Avg Revenue beat(16)-0.19%

PT rev (1m)-11.59%

PT rev (3m)-11.59%

EPS NQ rev (1m)1.34%

EPS NQ rev (3m)1.08%

EPS NY rev (1m)0%

EPS NY rev (3m)2.74%

Revenue NQ rev (1m)-4.2%

Revenue NQ rev (3m)-5.99%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-0.38%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.24
P/FCF	N/A
P/OCF	N/A
P/B	0.25
P/tB	0.36
EV/EBITDA	N/A

EPS(TTM)-7.89

EYN/A

EPS(NY)-5.34

Fwd EYN/A

FCF(TTM)-3.99

FCFYN/A

OCF(TTM)-3.84

OCFYN/A

SpS16.41

BVpS15.78

TBVpS11.17

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-31.56%
ROE	-44.5%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	52.93%
FCFM	N/A

ROA(3y)-61.48%

ROA(5y)-42.59%

ROE(3y)-79.72%

ROE(5y)-54.34%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.79%

GM growth 5Y-3.32%

F-Score6

Asset Turnover0.74

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	7.2%
Cap/Sales	0.92%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.14
Quick Ratio	3.11
Altman-Z	-7.23

F-Score6

WACC10.19%

ROIC/WACCN/A

Cap/Depr(3y)44.83%

Cap/Depr(5y)34.13%

Cap/Sales(3y)5.21%

Cap/Sales(5y)3.44%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)46.07%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%30.31%

EPS Next Y55.23%

EPS Next 2Y27.23%

EPS Next 3Y20.19%

EPS Next 5Y12.97%

Revenue 1Y (TTM)4.33%

Revenue growth 3Y0.21%

Revenue growth 5Y11.3%

Sales Q2Q%-7.8%

Revenue Next Year-0.84%

Revenue Next 2Y1.11%

Revenue Next 3Y2.87%

Revenue Next 5Y2.64%

EBIT growth 1Y52.11%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year78.39%

EBIT Next 3Y25.48%

EBIT Next 5Y15.81%

FCF growth 1Y61.42%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y56.53%

OCF growth 3YN/A

OCF growth 5YN/A

AMERICAN WELL CORP-CLASS A / AMWL FAQ

Can you provide the ChartMill fundamental rating for AMERICAN WELL CORP-CLASS A?

ChartMill assigns a fundamental rating of 3 / 10 to AMWL.

What is the valuation status for AMWL stock?

ChartMill assigns a valuation rating of 1 / 10 to AMERICAN WELL CORP-CLASS A (AMWL). This can be considered as Overvalued.

Can you provide the profitability details for AMERICAN WELL CORP-CLASS A?

AMERICAN WELL CORP-CLASS A (AMWL) has a profitability rating of 0 / 10.

What is the financial health of AMERICAN WELL CORP-CLASS A (AMWL) stock?

The financial health rating of AMERICAN WELL CORP-CLASS A (AMWL) is 7 / 10.

AMERICAN WELL CORP-CLASS A (AMWL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

AMERICAN WELL CORP-CLASS A / AMWL FAQ

Can you provide the ChartMill fundamental rating for AMERICAN WELL CORP-CLASS A?

What is the valuation status for AMWL stock?

Can you provide the profitability details for AMERICAN WELL CORP-CLASS A?

What is the financial health of AMERICAN WELL CORP-CLASS A (AMWL) stock?